Skip to content

Midazolam or Fentanyl as Adjuvants to Epidural Bupivacaine Plus Dexamethasone for Analgesia

Midazolam or Fentanyl as Adjuvants to Epidural Bupivacaine Plus Dexamethasone for Analgesia After Lumbar Spine Fixation: A Randomized Clinical Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06898697
Enrollment
100
Registered
2025-03-27
Start date
2025-04-01
Completion date
2025-12-01
Last updated
2026-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Spine Fixation

Brief summary

The purpose of this study is to compare better postoperative analgesia after lumbar spine Fixation using either epidural bupivacaine with midazolam or fentanyl with the combination of dexamethasone.

Detailed description

After being informed about the study and potential risks. A computer-generated randomization table will randomize all patients giving written consent into 2 groups, each containing 51 patients. In the Fentanyl Group :.Patients will receive 10 ml of bupivacaine 0. 25 % plus 100µg fentanyl in 2ml plus 2ml (8mg) dexamethasone.In Midazolam Group: Patients will receive 10 ml of bupivacaine 0.25 % plus 2mg midazolam in 2ml plus 2 ml (8mg) dexamethasone

Interventions

Fentanyl will be injected in the epidural space by the surgeon one or two levels above the surgical site.

DRUGepidural midazolam

midazolam will be injected in the epidural space by the surgeon one or two levels above the surgical site.

Sponsors

Zagazig University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
21 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

* Written informed consent from the patient. * Physical status: ASA 1\& II. * BMI = (25-30 kg/m2). * Type of operation: elective lumbar spine Fixation.

Exclusion criteria

* Altered mental state. * Patients with known history of allergy to study drugs. * Advanced hepatic, renal, cardiovascular, and respiratory diseases. * Patients with chronic pain. * Contraindications of regional anesthesia, e.g., allergy to local anesthetics, coagulopathy, or septic focus at site of injection.

Design outcomes

Primary

MeasureTime frame
the time to first call to rescue analgesia (ketorolac)day 1

Secondary

MeasureTime frameDescription
The Numerical Pain Rating Scale24 hours postoperative]A ten-centimeter Numerical Pain Rating Scale (0 - no pain and 10 - worst pain)
The total postoperative opioid consumption in the first 24 hours. opioid consumption24 hours postoperative
the duration of hospital stayup to 1 weekfrom the post operative day till discharge from hospital.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026